1,813
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The mechanisms of Huangqi Guizhi Wuwu decoction in treating ischaemic stroke based on network pharmacology and experiment verification

, , , , , , , , , , , & show all
Pages 1014-1029 | Received 17 Nov 2022, Accepted 22 Jun 2023, Published online: 06 Jul 2023

References

  • Ahmad A, Khan MM, Hoda MN, Raza SS, Khan MB, Javed H, Ishrat T, Ashafaq M, Ahmad ME, Safhi MM, et al. 2011. Quercetin protects against oxidative stress associated damages in a rat model of transient focal cerebral ischemia and reperfusion. Neurochem Res. 36(8):1360–1371. doi: 10.1007/s11064-011-0458-6.
  • Allen CL, Bayraktutan U. 2009. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 4(6):461–470. doi: 10.1111/j.1747-4949.2009.00387.x.
  • Amalia L, Sadeli HA, Parwati I, Rizal A, Panigoro R. 2020. Hypoxia-inducible factor-1alpha in acute ischemic stroke: neuroprotection for better clinical outcome. Heliyon. 6(6):e04286. doi: 10.1016/j.heliyon.2020.e04286.
  • Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. 2015. OMIM.org: online Mendelian inheritance in man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 43(Database issue):D789–798. doi: 10.1093/nar/gku1205.
  • Antwi AO, Obiri DD, Osafo N, Forkuo AD, Essel LB. 2017. Stigmasterol inhibits lipopolysaccharide-induced innate immune responses in murine models. Int Immunopharmacol. 53:105–113. doi: 10.1016/j.intimp.2017.10.018.
  • Baranova O, Miranda LF, Pichiule P, Dragatsis I, Johnson RS, Chavez JC. 2007. Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci. 27(23):6320–6332. doi: 10.1523/JNEUROSCI.0449-07.2007.
  • Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, et al. 2019. Heart disease and stroke statistics-2019 update: a report from the American heart association. Circulation. 139(10):e56–e528. doi: 10.1161/CIR.0000000000000659.
  • Boezio B, Audouze K, Ducrot P, Taboureau O. 2017. Network-based approaches in pharmacology. Mol Inf. 36(10):1700048. doi: 10.1002/minf.201700048.
  • Chen MC, Hsu WL, Hwang PA, Chou TC. 2015. Low molecular weight fucoidan inhibits tumor angiogenesis through downregulation of HIF-1/VEGF signaling under hypoxia. Mar Drugs. 13(7):4436–4451. doi: 10.3390/md13074436.
  • Chen S, Peng J, Sherchan P, Ma Y, Xiang S, Yan F, Zhao H, Jiang Y, Wang N, Zhang JH, et al. 2020. TREM2 activation attenuates neuroinflammation and neuronal apoptosis via PI3K/Akt pathway after intracerebral hemorrhage in mice. J Neuroinflammation. 17(1):168. doi: 10.1186/s12974-020-01853-x.
  • Chen Y, Li Y, Xu H, Li G, Ma Y, Pang YJ. 2017. Morin mitigates oxidative stress, apoptosis and inflammation in cerebral ischemic rats. Afr J Tradit Complement Altern Med. 14(2):348–355. doi: 10.21010/ajtcam.v14i2.36.
  • Chen ZZ, Gong X, Guo Q, Zhao H, Wang L. 2019. Bu Yang Huan Wu Decoction prevents reperfusion injury following ischemic stroke in rats via inhibition of HIF-1 alpha, VEGF and promotion beta-ENaC expression. J Ethnopharmacol. 228:70–81. doi: 10.1016/j.jep.2018.09.017.
  • Daina A, Michielin O, Zoete V. 2019. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47(W1):W357–W364. doi: 10.1093/nar/gkz382.
  • Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA, Allan SM. 2007. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab. 27(12):1941–1953. doi: 10.1038/sj.jcbfm.9600495.
  • Engelhardt S, Huang SF, Patkar S, Gassmann M, Ogunshola OO. 2015. Differential responses of blood-brain barrier associated cells to hypoxia and ischemia: a comparative study. Fluids Barriers CNS. 12:4. doi: 10.1186/2045-8118-12-4.
  • George PM, Steinberg GK. 2015. Novel stroke therapeutics: unraveling stroke pathophysiology and its impact on clinical treatments. Neuron. 87(2):297–309. doi: 10.1016/j.neuron.2015.05.041.
  • Gu P, Zhu L, Liu Y, Zhang L, Liu J, Shen H. 2017. Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice. Int Immunopharmacol. 50:152–160. doi: 10.1016/j.intimp.2017.06.022.
  • He Y, Zheng H, Zhong L, Zhong N, Wen G, Wang L, Zhang Y. 2021. Identification of active ingredients of Huangqi Guizhi Wuwu decoction for promoting nerve function recovery after ischemic stroke using HT22 live-cell-based affinity chromatography combined with HPLC-MS/MS. Drug Des Devel Ther. 15:5165–5178. doi: 10.2147/DDDT.S333418.
  • Jiang W, Zhang F, Zao B. 2017. Effect of Huangqi Guizhi Wuwu decoction on patients with convalescent cerebral infarction. World J Tradit Chin Med. 12:1555–1559.
  • Ke Q, Costa M. 2006. Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol. 70(5):1469–1480. doi: 10.1124/mol.106.027029.
  • Kibble M, Saarinen N, Tang J, Wennerberg K, Makela S, Aittokallio T. 2015. Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products. Nat Prod Rep. 32(8):1249–1266. doi: 10.1039/c5np00005j.
  • Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, et al. 2016. PubChem substance and compound databases. Nucleic Acids Res. 44(D1):D1202–1213. doi: 10.1093/nar/gkv951.
  • Li H, Zhao L, Zhang B, Jiang Y, Wang X, Guo Y, Liu H, Li S, Tong X. 2014. A network pharmacology approach to determine active compounds and action mechanisms of ge-gen-qin-lian decoction for treatment of type 2 diabetes. Evid Based Complement Alternat Med. 2014:495840. doi: 10.1155/2014/495840.
  • Liao SJ, Lin JW, Pei Z, Liu CL, Zeng JS, Huang RX. 2009. Enhanced angiogenesis with dl-3N-butylphthalide treatment after focal cerebral ischemia in RHRSP. Brain Res. 1289:69–78. doi: 10.1016/j.brainres.2009.06.018.
  • Liao W, Yu J, Guo Z, Ba W, Wang D, Li Z, Fan W, Liao F, Wu Y, Wang L. 2016. Microdialysis combined with UPLC-MS/MS method for determination of tetramethylpyrazine and ferulic acid in striatum of awake and anesthetic rats subjected to cerebral ischemia. J Pharm Biomed Anal. 128:510–518. doi: 10.1016/j.jpba.2016.06.030.
  • Liu D, Wang H, Zhang Y, Zhang Z. 2020. Protective effects of chlorogenic acid on cerebral ischemia/reperfusion injury rats by regulating oxidative stress-related Nrf2 pathway. Drug Des Devel Ther. 14:51–60. doi: 10.2147/DDDT.S228751.
  • Liu S, Levine SR, Winn HR. 2010. Targeting ischemic penumbra: part I - from pathophysiology to therapeutic strategy. J Exp Stroke Transl Med. 3(1):47–55. doi: 10.6030/1939-067x-3.1.47.
  • Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20(1):84–91. doi: 10.1161/01.str.20.1.84.
  • Lv MR, Li B, Wang MG, Meng FG, Yu JJ, Guo F, Li Y. 2017. Activation of the PI3K-Akt pathway promotes neuroprotection of the delta-opioid receptor agonist against cerebral ischemia-reperfusion injury in rat models. Biomed Pharmacother. 93:230–237. doi: 10.1016/j.biopha.2017.05.121.
  • Ma Y, Wang H, Yang P. 2016. Treatment of 80 cases of shoulder-hand syndrome after stroke with Huangqi Guizhi Wuwu Decoction combined with rehabilitation training. Chin Med Mod Distance Educ China. 14:76–80.
  • Nanetti L, Raffaelli F, Vignini A, Perozzi C, Silvestrini M, Bartolini M, Provinciali L, Mazzanti L. 2011. Oxidative stress in ischaemic stroke. Eur J Clin Invest. 41(12):1318–1322. doi: 10.1111/j.1365-2362.2011.02546.x.
  • Prabhakaran S, Ruff I, Bernstein RA. 2015. Acute stroke intervention: a systematic review. JAMA. 313(14):1451–1462. doi: 10.1001/jama.2015.3058.
  • Prlic A, Bliven S, Rose PW, Bluhm WF, Bizon C, Godzik A, Bourne PE. 2010. Pre-calculated protein structure alignments at the RCSB PDB website. Bioinformatics. 26(23):2983–2985. doi: 10.1093/bioinformatics/btq572.
  • Qutub AA, Popel AS. 2008. Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia. Mol Cell Biol. 28(16):5106–5119. doi: 10.1128/MCB.00060-08.
  • Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, et al. 2014. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 6:13. doi: 10.1186/1758-2946-6-13.
  • Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, et al. 2010. GeneCards Version 3: the human gene integrator. Database. 2010:baq020. doi: 10.1093/database/baq020.
  • Santos Samary C, Pelosi P, Leme Silva P, Rieken Macedo Rocco P. 2016. Immunomodulation after ischemic stroke: potential mechanisms and implications for therapy. Crit Care. 20(1):391. doi: 10.1186/s13054-016-1573-1.
  • Sarkar S, Chakraborty D, Bhowmik A, Ghosh MK. 2019. Cerebral ischemic stroke: cellular fate and therapeutic opportunities. Front Biosci. 24(3):435–450. doi: 10.2741/4727.
  • Shen Y, Zhang B, Pang X, Yang R, Chen M, Zhao J, Wang J, Wang Z, Yu Z, Wang Y, et al. 2020. Network pharmacology-based analysis of Xiao-Xu-Ming decoction on the treatment of Alzheimer’s disease. Front Pharmacol. 11:595254. doi: 10.3389/fphar.2020.595254.
  • Shi Q, Zhang P, Zhang J, Chen X, Lu H, Tian Y, Parker TL, Liu Y. 2009. Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice. Neurosci Lett. 465(3):220–225. doi: 10.1016/j.neulet.2009.08.049.
  • Soares ROS, Losada DM, Jordani MC, Evora P, Castro ESO. 2019. Ischemia/reperfusion injury revisited: an overview of the latest pharmacological strategies. IJMS. 20(20):5034. doi: 10.3390/ijms20205034.
  • Szklarczyk D, Morris JH, Cook H, Kuhn M, Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al. 2017. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 45(D1):D362–D368. doi: 10.1093/nar/gkw937.
  • UniProt C. 2021. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49(D1):D480–D489.
  • Wang L, Wang L, Wang H, Zhu T. 2022. Investigation into the potential mechanism and molecular targets of Fufang Xueshuantong capsule for the treatment of ischemic stroke based on network pharmacology and molecular docking. Front Pharmacol. 13:949644. doi: 10.3389/fphar.2022.949644.
  • Wang Y, Thilmony R, Gu YQ. 2014. NetVenn: an integrated network analysis web platform for gene lists. Nucleic Acids Res. 42(Web Server issue):W161–166. doi: 10.1093/nar/gku331.
  • Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, Sandercock P, Wang Y, Huang Y, Cui L, et al. 2019. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 18(4):394–405. doi: 10.1016/S1474-4422(18)30500-3.
  • Xie W, Zhu T, Zhang S, Sun X. 2022. Protective effects of Gypenoside XVII against cerebral ischemia/reperfusion injury via SIRT1-FOXO3A- and Hif1a-BNIP3-mediated mitochondrial autophagy. J Transl Med. 20(1):622. doi: 10.1186/s12967-022-03830-9.
  • Xu J, Guan Z, Wang X, Sun D, Li Y, Pei B, Lu Y, Yuan L, Zhang X. 2021. Network pharmacology and experimental evidence identify the mechanism of astragaloside IV in oxaliplatin neurotoxicity. Drug Des Devel Ther. 15:99–110. doi: 10.2147/DDDT.S262818.
  • Xu W, Zheng J, Gao L, Li T, Zhang J, Shao A. 2017. Neuroprotective effects of stem cells in ischemic stroke. Stem Cells Int. 2017:4653936. doi: 10.1155/2017/4653936.
  • Yang T, Chen X, Mei Z, Liu X, Feng Z, Liao J, Deng Y, Ge J. 2021. An integrated analysis of network pharmacology and experimental validation to reveal the mechanism of Chinese medicine formula Naotaifang in treating cerebral ischemia-reperfusion injury. Drug Des Devel Ther. 15:3783–3808. doi: 10.2147/DDDT.S328837.
  • Yin Y, Ren H. 2017. Treatment of 46 cases of sequelae of cerebral infarction with Huangqi Guizhi Wuwu decoction. Inner Mongolia Tradit Chin Med. 36:11–14.
  • Zhang H, Dong R, Zhang P, Wang Y. 2019. Songorine suppresses cell growth and metastasis in epithelial ovarian cancer via the Bcl2/Bax and GSK3beta/betacatenin signaling pathways. Oncol Rep. 41(5):3069–3079. doi: 10.3892/or.2019.7070.
  • Zhang R, Zhu X, Bai H, Ning K. 2019. Network pharmacology databases for traditional Chinese medicine: review and assessment. Front Pharmacol. 10:123. doi: 10.3389/fphar.2019.00123.
  • Zhang Y, Bai M, Zhang B, Liu C, Guo Q, Sun Y, Wang D, Wang C, Jiang Y, Lin N, et al. 2015. Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation. Sci Rep. 5:9463. doi: 10.1038/srep09463.
  • Zhang ZJ, Cheang LC, Wang MW, Lee SM. 2011. Quercetin exerts a neuroprotective effect through inhibition of the iNOS/NO system and pro-inflammation gene expression in PC12 cells and in zebrafish. Int J Mol Med. 27(2):195–203. doi: 10.3892/ijmm.2010.571.
  • Zheng HZ, Shen X, He YY, Yan XL, Wang SX, Yu AM, Wang LS. 2020. Pharmacokinetic analysis of Huangqi Guizhi Wuwu decoction on blood and brain tissue in rats with normal and cerebral ischemia-reperfusion injury by microdialysis with HPLC-MS/MS. Drug Des Devel Ther. 14:2877–2888. doi: 10.2147/DDDT.S257020.
  • Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. 2019. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 10(1):1523. doi: 10.1038/s41467-019-09234-6.
  • Ziello JE, Jovin IS, Huang Y. 2007. Hypoxia-Inducible Factor (HIF)-1 regulatory pathway and its potential for therapeutic intervention in malignancy and ischemia. Yale J Biol Med. 80(2):51–60.